vs
Side-by-side financial comparison of CONSTELLIUM SE (CSTM) and SELECT MEDICAL HOLDINGS CORP (SEM). Click either name above to swap in a different company.
CONSTELLIUM SE is the larger business by last-quarter revenue ($2.2B vs $1.4B, roughly 1.5× SELECT MEDICAL HOLDINGS CORP). CONSTELLIUM SE runs the higher net margin — 5.1% vs 4.5%, a 0.6% gap on every dollar of revenue.
Constellium SE is an American-Swiss, French-based global manufacturer of aluminium rolled products, extruded products, and structural parts based on a large variety of advanced alloys. Constellium's C-TEC research center has been credited for advancing technology in the field of advanced aluminium alloy. Constellium primarily serves the aerospace, automotive, and packaging sectors. Large clients include Mercedes-Benz, Audi, BMW, Fiat Chrysler Automotive, Ford, Airbus, Boeing, and Bombardier.
Select Medical is a healthcare company based in Pennsylvania. It owns long-term acute care and inpatient rehabilitation hospitals, as well as occupational health and physical therapy clinics. Select Medical is a subsidiary of Select Medical Holdings, which is listed on the New York Stock Exchange.
CSTM vs SEM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $2.2B | $1.4B |
| Net Profit | $112.0M | $63.8M |
| Gross Margin | — | — |
| Operating Margin | 7.5% | 6.9% |
| Net Margin | 5.1% | 4.5% |
| Revenue YoY | — | 5.0% |
| Net Profit YoY | — | -14.7% |
| EPS (diluted) | $0.79 | $0.35 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $1.4B | ||
| Q4 25 | $2.2B | $1.4B | ||
| Q3 25 | $2.2B | $1.4B | ||
| Q2 25 | $2.1B | $1.3B | ||
| Q1 25 | $2.0B | $1.4B | ||
| Q4 24 | — | $1.3B | ||
| Q3 24 | — | $1.3B | ||
| Q2 24 | $1.9B | $1.3B |
| Q1 26 | — | $63.8M | ||
| Q4 25 | $112.0M | $20.2M | ||
| Q3 25 | $88.0M | $28.8M | ||
| Q2 25 | $36.0M | $40.6M | ||
| Q1 25 | $37.0M | $56.7M | ||
| Q4 24 | — | $-16.1M | ||
| Q3 24 | — | $55.6M | ||
| Q2 24 | $76.0M | $77.6M |
| Q1 26 | — | 6.9% | ||
| Q4 25 | 7.5% | 4.6% | ||
| Q3 25 | 5.8% | 5.4% | ||
| Q2 25 | 2.7% | 6.5% | ||
| Q1 25 | 3.1% | 8.3% | ||
| Q4 24 | — | 1.6% | ||
| Q3 24 | — | 4.3% | ||
| Q2 24 | 5.4% | 5.8% |
| Q1 26 | — | 4.5% | ||
| Q4 25 | 5.1% | 1.4% | ||
| Q3 25 | 4.1% | 2.1% | ||
| Q2 25 | 1.7% | 3.0% | ||
| Q1 25 | 1.9% | 4.2% | ||
| Q4 24 | — | -1.2% | ||
| Q3 24 | — | 4.4% | ||
| Q2 24 | 3.9% | 6.1% |
| Q1 26 | — | $0.35 | ||
| Q4 25 | $0.79 | $0.17 | ||
| Q3 25 | $0.62 | $0.23 | ||
| Q2 25 | $0.25 | $0.32 | ||
| Q1 25 | $0.26 | $0.44 | ||
| Q4 24 | — | $-0.12 | ||
| Q3 24 | — | $0.43 | ||
| Q2 24 | $0.51 | $0.60 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $120.0M | $25.7M |
| Total DebtLower is stronger | $1.9B | $1.8B |
| Stockholders' EquityBook value | $952.0M | $2.1B |
| Total Assets | $5.4B | $6.0B |
| Debt / EquityLower = less leverage | 2.00× | 0.88× |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $25.7M | ||
| Q4 25 | $120.0M | $26.5M | ||
| Q3 25 | $122.0M | $60.1M | ||
| Q2 25 | $133.0M | $52.3M | ||
| Q1 25 | $118.0M | $53.2M | ||
| Q4 24 | — | $59.7M | ||
| Q3 24 | — | $191.5M | ||
| Q2 24 | — | $111.2M |
| Q1 26 | — | $1.8B | ||
| Q4 25 | $1.9B | $1.8B | ||
| Q3 25 | $2.0B | $1.7B | ||
| Q2 25 | $2.0B | $1.8B | ||
| Q1 25 | $1.9B | $1.8B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $3.1B | ||
| Q2 24 | — | $3.6B |
| Q1 26 | — | $2.1B | ||
| Q4 25 | $952.0M | $1.7B | ||
| Q3 25 | $845.0M | $1.7B | ||
| Q2 25 | $780.0M | $1.7B | ||
| Q1 25 | $745.0M | $1.7B | ||
| Q4 24 | — | $1.7B | ||
| Q3 24 | — | $1.9B | ||
| Q2 24 | $796.0M | $1.4B |
| Q1 26 | — | $6.0B | ||
| Q4 25 | $5.4B | $5.9B | ||
| Q3 25 | $5.4B | $5.7B | ||
| Q2 25 | $5.4B | $5.7B | ||
| Q1 25 | $5.2B | $5.7B | ||
| Q4 24 | — | $5.6B | ||
| Q3 24 | — | $8.0B | ||
| Q2 24 | — | $7.9B |
| Q1 26 | — | 0.88× | ||
| Q4 25 | 2.00× | 1.06× | ||
| Q3 25 | 2.34× | 1.03× | ||
| Q2 25 | 2.53× | 1.10× | ||
| Q1 25 | 2.56× | 1.03× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | — | 1.62× | ||
| Q2 24 | — | 2.54× |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $218.0M | — |
| Free Cash FlowOCF − Capex | $109.0M | — |
| FCF MarginFCF / Revenue | 5.0% | — |
| Capex IntensityCapex / Revenue | 5.0% | — |
| Cash ConversionOCF / Net Profit | 1.95× | — |
| TTM Free Cash FlowTrailing 4 quarters | $159.0M | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | — | ||
| Q4 25 | $218.0M | $64.3M | ||
| Q3 25 | $99.0M | $175.3M | ||
| Q2 25 | $114.0M | $110.3M | ||
| Q1 25 | $58.0M | $-3.5M | ||
| Q4 24 | — | $125.4M | ||
| Q3 24 | — | $181.0M | ||
| Q2 24 | $138.0M | $278.2M |
| Q1 26 | — | — | ||
| Q4 25 | $109.0M | $5.2M | ||
| Q3 25 | $24.0M | $122.2M | ||
| Q2 25 | $37.0M | $45.6M | ||
| Q1 25 | $-11.0M | $-55.8M | ||
| Q4 24 | — | $62.0M | ||
| Q3 24 | — | $130.3M | ||
| Q2 24 | $54.0M | $222.6M |
| Q1 26 | — | — | ||
| Q4 25 | 5.0% | 0.4% | ||
| Q3 25 | 1.1% | 9.0% | ||
| Q2 25 | 1.8% | 3.4% | ||
| Q1 25 | -0.6% | -4.1% | ||
| Q4 24 | — | 4.7% | ||
| Q3 24 | — | 10.2% | ||
| Q2 24 | 2.8% | 17.4% |
| Q1 26 | — | — | ||
| Q4 25 | 5.0% | 4.2% | ||
| Q3 25 | 3.5% | 3.9% | ||
| Q2 25 | 3.7% | 4.8% | ||
| Q1 25 | 3.5% | 3.9% | ||
| Q4 24 | — | 4.8% | ||
| Q3 24 | — | 4.0% | ||
| Q2 24 | 4.3% | 4.3% |
| Q1 26 | — | — | ||
| Q4 25 | 1.95× | 3.19× | ||
| Q3 25 | 1.13× | 6.09× | ||
| Q2 25 | 3.17× | 2.72× | ||
| Q1 25 | 1.57× | -0.06× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 3.25× | ||
| Q2 24 | 1.82× | 3.59× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
CSTM
| Packaging Rolled Products | $1.0B | 46% |
| Automotive Rolled Products | $318.0M | 14% |
| Aerospace Rolled Products | $270.0M | 12% |
| Transportation Industry Defense And Other Rolled Products | $232.0M | 11% |
| Automotive Extruded Products | $220.0M | 10% |
| Other Extruded Products | $132.0M | 6% |
| Specialty And Other Thin Rolled Products | $22.0M | 1% |
SEM
Segment breakdown not available.
